Vivaldi Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,384
| Closed | -$206K | – | 297 |
|
|
2025
Q1 | $206K | Buy |
+3,384
| New | +$197K | 0.03% | 260 |
|
|
2024
Q2 | – | Sell |
-4,490
| Closed | -$202K | – | 231 |
|
|
2024
Q1 | $202K | Sell |
4,490
-718
| -14% | -$36.6K | 0.06% | 211 |
|
|
2023
Q4 | $254K | Buy |
5,208
+83
| +2% | +$4.36K | 0.08% | 182 |
|
|
2023
Q3 | $297K | Buy |
5,125
+380
| +8% | +$23.3K | 0.1% | 146 |
|
|
2023
Q2 | $303K | Sell |
4,745
-58
| -1% | -$3.89K | 0.09% | 144 |
|
|
2023
Q1 | $333K | Sell |
4,803
-10
| -0.2% | -$705 | 0.1% | 143 |
|
|
2022
Q4 | $342K | Sell |
4,813
-59
| -1% | -$4.45K | 0.08% | 169 |
|
|
2022
Q3 | $340K | Buy |
4,872
+42
| +0.9% | +$3.05K | 0.09% | 152 |
|
|
2022
Q2 | $372K | Buy |
4,830
+193
| +4% | +$14.7K | 0.1% | 147 |
|
|
2022
Q1 | $351K | Sell |
4,637
-102
| -2% | -$6.85K | 0.09% | 155 |
|
|
2021
Q4 | $295K | Buy |
4,739
+15
| +0.3% | +$880 | 0.07% | 165 |
|
|
2021
Q3 | $280K | Hold |
4,724
| – | – | 0.06% | 184 |
|
|
2021
Q2 | $319K | Sell |
4,724
-240
| -5% | -$15.6K | 0.06% | 184 |
|
|
2021
Q1 | $322K | Sell |
4,964
-1,465
| -23% | -$91.1K | 0.06% | 187 |
|
|
2020
Q4 | $399K | Buy |
6,429
+85
| +1% | +$5.23K | 0.09% | 157 |
|
|
2020
Q3 | $404K | Sell |
6,344
-131
| -2% | -$7.88K | 0.09% | 154 |
|
|
2020
Q2 | $412K | Buy |
6,475
+1,378
| +27% | +$82.4K | 0.09% | 153 |
|
|
2020
Q1 | $284K | Buy |
5,097
+210
| +4% | +$12.8K | 0.06% | 156 |
|
|
2019
Q4 | $314K | Sell |
4,887
-518
| -10% | -$29.7K | 0.08% | 165 |
|
|
2019
Q3 | $274K | Buy |
+5,405
| New | +$254K | 0.06% | 175 |
|
Other funds holding BMY
